Literature DB >> 18595661

Grapefruit pulp increases antioxidant status and improves bone quality in orchidectomized rats.

Farzad Deyhim1, Kranthi Mandadi, Bhimanagouda S Patil, Bahram Faraji.   

Abstract

OBJECTIVE: Orchidectomy causes oxidative stress and increases the incidence of osteoporosis. The objective of this research was to evaluate whether eating grapefruit pulp (GP) modifies antioxidant status and reduces osteoporosis in orchidectomized rats.
METHODS: Fifty-six 90-d-old male Sprague-Dawley rats were randomized into two groups: sham-control group (n = 14) and orchidectomized (ORX) group (n = 42). The orchidectomized group was equally divided among the following three treatments: orchidectomy, orchidectomy + 5.0% GP, and orchidectomy + 10% GP. At the termination of the study (day 60), all rats were euthanized and the plasma was collected for antioxidant status and indices of bone turnover. Bone quality and mineral contents in the bone, urine, and feces were evaluated.
RESULTS: Orchidectomy lowered (P < 0.05) antioxidant status, bone quality, bone mineral contents and elevated (P < 0.05) indices of bone turnover, urinary deoxypyridinoline, and fecal calcium excretion. In contrast to the ORX group, independent of dosage, antioxidant status, bone density, and delayed time-induced femoral fracture were higher (P < 0.05) in the GP groups, whereas fecal calcium excretion and urinary deoxypyridinoline excretion were lowered (P < 0.05). GP dose-dependently slowed down bone turnover (P < 0.05), elevated bone calcium and magnesium contents (P < 0.05), tended to lower urinary excretion of magnesium, and numerically improved bone strength.
CONCLUSION: The beneficial effects of eating red grapefruit on bone quality of ORX rats is due to bone mineral deposition and slowed-down bone turnover.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595661     DOI: 10.1016/j.nut.2008.05.005

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  7 in total

1.  Inhibitory effect of grapefruit juice on the genotoxic damage induced by ifosfamide in mouse.

Authors:  Isela Alvarez-González; Eduardo Madrigal-Bujaidar; Vanesa Y Sánchez-García
Journal:  Plant Foods Hum Nutr       Date:  2010-12       Impact factor: 3.921

2.  Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells.

Authors:  Wai-Yin Pang; Xin-Lun Wang; Sau-Keng Mok; Wan-Ping Lai; Hung-Kay Chow; Ping-Chung Leung; Xin-Sheng Yao; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

3.  Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study.

Authors:  Jiwon Hwang; Jung Hye Hwang; Seungho Ryu; Joong Kyong Ahn
Journal:  J Bone Miner Metab       Date:  2018-01-25       Impact factor: 2.626

Review 4.  Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest.

Authors:  Renato Bruni; Davide Barreca; Michele Protti; Virginia Brighenti; Laura Righetti; Lisa Anceschi; Laura Mercolini; Stefania Benvenuti; Giuseppe Gattuso; Federica Pellati
Journal:  Molecules       Date:  2019-06-08       Impact factor: 4.411

5.  Potential antiosteoporotic agents from plants: a comprehensive review.

Authors:  Min Jia; Yan Nie; Da-Peng Cao; Yun-Yun Xue; Jie-Si Wang; Lu Zhao; Khalid Rahman; Qiao-Yan Zhang; Lu-Ping Qin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

6.  Naringenin inhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes.

Authors:  Allison J Richard; Zhaleh Amini-Vaughan; David M Ribnicky; Jacqueline M Stephens
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-29       Impact factor: 2.629

Review 7.  Chemistry and health effects of furanocoumarins in grapefruit.

Authors:  Wei-Lun Hung; Joon Hyuk Suh; Yu Wang
Journal:  J Food Drug Anal       Date:  2016-12-06       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.